16 results on '"Yao, Shifei"'
Search Results
2. IL-27 mediates immune response of pneumococcal vaccine SPY1 through Th17 and memory CD4+T cells
- Author
-
Zhang, Yanyu, Gao, Song, Yao, Shifei, Weng, Danlin, Wang, Yan, Huang, Qi, Zhang, Xuemei, Wang, Hong, and Xu, Wenchun
- Published
- 2023
- Full Text
- View/download PDF
3. Protein Kinase CK2 Promotes Proliferation, Abnormal Differentiation, and Proinflammatory Cytokine Production of Keratinocytes via Regulation of STAT3 and Akt Pathways in Psoriasis
- Author
-
Huang, Wenjie, Zheng, Xuyu, Huang, Qi, Weng, Danlin, Yao, Shifei, Zhou, Cui, Li, Qian, Hu, Yulian, Xu, Wenchun, and Huang, Kun
- Published
- 2023
- Full Text
- View/download PDF
4. The preprogrammed anti-inflammatory phenotypes of CD11chigh macrophages by Streptococcus pneumoniae aminopeptidase N safeguard from allergic asthma.
- Author
-
Yao, Shifei, Weng, Danlin, Wang, Yan, Zhang, Yanyu, Huang, Qi, Wu, Kaifeng, Li, Honghui, Zhang, Xuemei, Yin, Yibing, and Xu, Wenchun
- Subjects
- *
ALANINE aminopeptidase , *STREPTOCOCCUS pneumoniae , *MACROPHAGES , *PROTEIN kinases , *OVALBUMINS , *BONE marrow , *ASTHMA - Abstract
Background: Early microbial exposure is associate with protective allergic asthma. We have previously demonstrated that Streptococcus pneumoniae aminopeptidase N (PepN), one of the pneumococcal components, inhibits ovalbumin (OVA) -induced airway inflammation in murine models of allergic asthma, but the underlying mechanism was incompletely determined. Methods: BALB/c mice were pretreated with the PepN protein and exposed intranasally to HDM allergen. The anti-inflammatory mechanisms were investigated using depletion and adoptive transfer experiments as well as transcriptome analysis and isolated lung CD11chigh macrophages. Results: We found pretreatment of mice with PepN promoted the proliferation of lung-resident F4/80+CD11chigh macrophages in situ but also mobilized bone marrow monocytes to infiltrate lung tissue that were then transformed into CD11high macrophages. PepN pre-programmed the macrophages during maturation to an anti-inflammatory phenotype by shaping the metabolic preference for oxidative phosphorylation (OXPHOS) and also inhibited the inflammatory response of macrophages by activating AMP-activated protein kinase. Furthermore, PepN treated macrophages also exhibited high-level costimulatory signaling molecules which directed the differentiation into Treg. Conclusion: Our results demonstrated that the expansion of CD11chigh macrophages in lungs and the OXPHOS metabolic bias of macrophages are associated with reduced allergic airway inflammation after PepN exposure, which paves the way for its application in preventing allergic asthma. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
5. Progranulin deficiency suppresses allergic asthma and enhances efferocytosis via PPAR‐γ/MFG‐E8 regulation in macrophages.
- Author
-
Huang, Qi, Weng, Danlin, Yao, Shifei, Shen, Hailan, Gao, Song, Zhang, Yanyu, Huang, Wenjie, Wang, Yan, Wang, Hong, and Xu, Wenchun
- Subjects
PEROXISOME proliferator-activated receptors ,PROGRANULIN ,PERITONEAL macrophages ,ASTHMA ,MACROPHAGES ,MILKFAT ,OVALBUMINS - Abstract
Efferocytosis can resolve airway inflammation and enhance airway tolerance in allergic asthma. While previous work has reported that progranulin (PGRN) regulated macrophage efferocytosis, but it is unclear whether PGRN‐mediated efferocytosis is associated with asthma. Here, we found that in an ovalbumin (OVA)‐induced allergic asthma model, the airway inflammation was suppressed and the apoptosis in lung tissues was ameliorated in PGRN‐deficient mice. In contrast, PGRN knockdown in human bronchial epithelial cells increased apoptosis in vitro. Furthermore, PGRN‐deficient macrophages had significantly stronger efferocytosis ability than wild type (WT) macrophages both in vitro and in vivo. PGRN‐deficient peritoneal macrophages (PMs) exhibited increased expression of genes associated with efferocytosis including milk fat globule‐epidermal growth factor 8 (MFG‐E8), peroxisome proliferator‐activated receptor gamma (PPAR‐γ) and sirtuin1 (SIRT1) and increased capacity to produce the anti‐inflammatory mediator interleukin (IL)‐10 during efferocytosis. GW9662, the inhibitor of PPAR‐γ, abolished increased efferocytosis and MFG‐E8 expression in PGRN‐deficient PMs suggesting that PGRN deficiency enhanced MFG‐E8‐mediated efferocytosis through PPAR‐γ. Correspondingly, efferocytosis genes were increased in the lungs of OVA‐induced PGRN‐deficient mice. GW9662 treatment reduced MFG‐E8 expression but did not significantly affect airway inflammation. Our results demonstrated that PGRN deficiency enhanced efferocytosis via the PPAR‐γ/MFG‐E8 pathway and this may be one of the reasons PGRN deficiency results in inhibition of airway inflammation in allergic asthma. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
6. CD5L attenuates allergic airway inflammation by expanding CD11chigh alveolar macrophages and inhibiting NLRP3 inflammasome activation via HDAC2.
- Author
-
Weng, Danlin, Gao, Song, Shen, Hailan, Yao, Shifei, Huang, Qi, Zhang, Yanyu, Huang, Wenjie, Wang, Yan, Zhang, Xuemei, Yin, Yibing, and Xu, Wenchun
- Subjects
ALVEOLAR macrophages ,NLRP3 protein ,INFLAMMASOMES ,HOUSE dust mites - Abstract
Allergic asthma is an airway inflammatory disease dominated by type 2 immune responses and there is currently no curative therapy for asthma. CD5‐like antigen (CD5L) has been known to be involved in a variety of inflammatory diseases. However, the role of CD5L in allergic asthma remains unclear. In the present study, mice were treated with recombinant CD5L (rCD5L) during house dust mite (HDM) and ovalbumin (OVA) challenge to determine the role of CD5L in allergic asthma, and the underlying mechanism was further explored. Compared with PBS group, serum CD5L levels of asthmatic mice were significantly decreased, and the levels of CD5L in lung tissues and bronchoalveolar lavage fluid (BALF) were significantly increased. CD5L reduced airway inflammation and Th2 immune responses in asthmatic mice. CD5L exerted its anti‐inflammatory function by increasing CD11chigh alveolar macrophages (CD11chigh AMs), and the anti‐inflammatory role of CD11chigh AMs in allergic asthma was confirmed by CD11chigh AMs depletion and transfer assays. In addition, CD5L increased the CD5L+ macrophages and inhibited NLRP3 inflammasome activation by increasing HDAC2 expression in lung tissues of asthmatic mice. Hence, our study implicates that CD5L has potential usefulness for asthma treatment. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
7. Elevated Serum Levels of Progranulin and Soluble Vascular Cell Adhesion Molecule-1 in Patients with COVID-19.
- Author
-
Yao, Shifei, Luo, Nanning, Liu, Jiaoyang, Zha, He, Ai, Yuanhang, Luo, Juan, Shi, Shi, and Wu, Kaifeng
- Subjects
VASCULAR cell adhesion molecule-1 ,COVID-19 ,HOSPITAL admission & discharge ,PROGRANULIN ,ENZYME-linked immunosorbent assay ,SARS-CoV-2 - Abstract
Background: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is associated with the angiocentric inflammation and angiogenesis, yet the molecules involved in this process remain to be determined. Methods: We did a cross-sectional study of a cohort of patients with COVID-19 in Zunyi, China between February 1 and March 30, 2020. Serum concentrations of PGRN were determined by enzyme-linked immunosorbent assay in patients with COVID-19 at hospital admission and at discharge. In parallel, the serum levels of soluble adhesion molecules, vascular cell adhesion molecule-1 (sVCAM-1), intercellular adhesion molecule-1 (sICAM-1), P-selectin (sP-selectin), and E-selectin (sE-selectin) were assayed by a human adhesion molecule multiplex kit. The association between serum PGRN levels and other laboratory test results was analyzed by Spearman correlation analysis. Results: At baseline, the median serum PGRN levels in patients with COVID-19 were 94.8 ng/mL [interquartile range (IQR): 66.6– 119.6 ng/mL], which was significantly elevated compared with those in healthy controls (46.3 ng/mL, IQR: 41.8– 55.6 ng/mL). Moreover, the median serum sVCAM-1 levels were significantly higher in COVID-19 patients (1396.0 ng/mL, IQR: 1019.1– 1774.8 ng/mL) than those in healthy controls (612.4 ng/mL, IQR: 466.4– 689.3 ng/mL). However, the levels of sICAM-1, sP-selectin, and sE-selectin were not significantly elevated in patients with COVID-19 when compared to healthy controls. Further analysis showed that serum PGRN levels were significantly positively associated with sVCAM-1 (r= 0.675, P= 0.008) and inversely with sICAM-1 (r= − 0.609, P= 0.021) and aspartate aminotransferase levels (r= − 0.560, P= 0.037) in patients with COVID-19 at hospital admission. In COVID-19 patients, serum PGRN and sVCAM-1 levels fell significantly after successful treatment. Conclusion: The present study demonstrates elevated serum PGRN and sVCAM-1 levels in patients with COVID-19, which may provide clues as to the mechanisms underlying the pathogenesis of COVID-19. Further studies are warranted to evaluate the potential of PGRN and sVCAM-1 as biomarkers and investigate their role in the pathogenesis of COVID-19. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
8. Prevalence and clinical significance of common respiratory pathogens in the upper respiratory tract of children with community‐acquired pneumonia in Zunyi, China.
- Author
-
Li, Xinmiao, Zhang, Weiwei, Yao, Shifei, Zha, He, Huang, Bo, Liu, Daishun, and Wu, Kaifeng
- Published
- 2020
- Full Text
- View/download PDF
9. Effects of lapatinib on cell proliferation and apoptosis in NB4 cells.
- Author
-
Liu, Lu, Zhong, Liang, Zhao, Yi, Chen, Min, Yao, Shifei, Li, Lianwen, Xiao, Chunlan, Shan, Zhiling, Gan, Liugen, Xu, Ting, and Liu, Beizhong
- Subjects
LAPATINIB ,TREATMENT of acute promyelocytic leukemia ,CELL proliferation ,RETINOIC acid receptors ,APOPTOSIS ,THERAPEUTICS - Abstract
Acute promyelocytic leukemia (APL), characterized by the presence of the promyelocytic leukemia (PML)-retinoic acid α receptor (RARα) fusion protein, responds to treatment with all-trans retinoic acid (ATRA) and arsenic trioxide (ATO). However, drug resistance and side effects restrict the application of these reagents. Hence, the development of novel therapeutic drugs for APL treatment is critical. Lapatinib, a small-molecule tyrosine kinase inhibitor, has been used in the treatment of different tumors. However, it is unclear whether lapatinib exerts antitumor effects on APL. The present study investigated the antitumor effects and potential mechanisms of lapatinib on NB4 cells derived from APL. Cell Counting Kit-8 assay and colony forming analysis indicated that lapatinib inhibited NB4 cell proliferation in a dose-dependent manner. Flow cytometry analysis revealed that lapatinib induced cell cycle arrest at the S phase and promoted cell apoptosis. Furthermore, Liu's staining and Hoechst 33258 staining revelaed that lapatinib treatment induced an apoptotic nuclear phenomenon. Furthermore, lapatinib induced apoptosis by decreasing Bcl-2 and PML-RARα levels, and by increasing the levels of Bax, cleaved PARP, cleaved caspase-3 and cleaved caspase-9. In addition, lapatinib increased the levels of phospho-p38 MAPK and phospho-JNK, and decreased the levels of phospho-Akt. The p38 inhibitor PD169316 partially blocked lapatinib-induced proliferation inhibition and apoptosis, whereas the JNK inhibitor SP600125 had no such effects. Therefore, treatment with lapatinib may be a promising strategy for APL therapy. [ABSTRACT FROM AUTHOR]
- Published
- 2018
- Full Text
- View/download PDF
10. MiR-15b regulates cell differentiation and survival by targeting CCNE1 in APL cell lines.
- Author
-
Yuan, Zhen, Zhong, Liang, Liu, Dongdong, Yao, Juanjuan, Liu, Junmei, Zhong, Pengqiang, Yao, Shifei, Zhao, Yi, Li, Lianwen, Chen, Min, Liu, Lu, and Liu, Beizhong
- Subjects
- *
CELL differentiation , *ACUTE promyelocytic leukemia , *CELL lines , *CELL cycle , *CELL proliferation - Abstract
MicroRNAs have been shown to be involved in various cell processes, including proliferation, apoptosis and differentiation. However, little is known about their function in granulopoiesis. In the present study, overexpression and knockdown experiments revealed that miR-15b was required to block the proliferation of NB4 and HL60 cells and induce them differentiated to granulocyte lineage. Moreover, we identified CCNE1 as a direct target of miR-15b, and demonstrated that CCNE1 was involved in cell differentiation and proliferation in acute promyelocytic leukemia cells. In addition, we demonstrated a novel pathway in which miR-15b regulated cells arrested in the G0/G1 phase and promoted terminal differentiation of cells by targeting CCNE1, which could modulate the cell cycle effort pRb in APL cells. These events blocked cell proliferation and promoted granulocyte differentiation. In conclusion, our data highlighted, for the first time, the important role of miR-15b in myeloid differentiation and suggested the potential role of miR-15b in cancer therapy. • miR-15b has an important function in the differentiation and proliferation of acute promyelocytic leukemia. • miR-15b serves as a tumor suppressor by targeting CCNE1. • miR-15b may be a novel therapeutic strategy for APL in the future. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
11. miR-382-5p modulates the ATRA-induced differentiation of acute promyelocytic leukemia by targeting tumor suppressor PTEN.
- Author
-
Liu, Dongdong, Zhong, Liang, Yuan, Zhen, Yao, Juanjuan, Zhong, Pengqiang, Liu, Junmei, Yao, Shifei, Zhao, Yi, Liu, Lu, Chen, Min, Li, Lianwen, and Liu, Beizhong
- Subjects
- *
TUMOR suppressor proteins , *ACUTE promyelocytic leukemia , *CELL differentiation , *GENE expression , *PHENOTYPES - Abstract
Abstract In acute promyelocytic leukemia (APL), all-trans retinoic acid (ATRA) treatment induces granulocytic differentiation and maturation. MicroRNAs play pivotal roles in formation of the leukemic phenotype. Previously, microRNA-382-5p (miR-382-5p) was upregulated in acute myeloid leukemia (AML) with t(15;17). In the present study, we found that miR-382-5p expression was elevated with ATRA-induced differentiation of APL. To investigate the potential functional role of miR-382-5p in APL differentiation, an APL cell line was transfected with miR-382-5p mimics, inhibitors, or negative control (NC). The results showed in APL cell line NB4 that miR-382-5p downregulation upon ATRA treatment was a key event in the drug response. Mechanistic investigations revealed that miR-382-5p targeted the ATRA-regulated tumor suppressor gene PTEN through direct binding to its 3′ UTR. Enforced expression of miR-382-5p or specific PTEN inhibitors inhibited ATRA-induced granulocytic differentiation via regulation of the cell cycle regulator cyclinD1. Conversely, PTEN overexpression promoted differentiation and enhanced sensitivity of NB4 cell line to physiological levels of ATRA. Finally, we found that PTEN overexpression restored PML nuclear bodies (NBs). Taken together, these results demonstrated that up-regulated miR-382-5p in NB4 cell line inhibited granulocytic differentiation through the miR-382-5p/PTEN axis, uncovering PTEN as a critical element in the granulocytic differentiation program induced by ATRA in APL. Graphical abstract Unlabelled Image Highlights • micoRNA-382-5p has a great influence in the differentiation of ATRA-induced acute promyelocytic leukemia. • PTEN sensitizes NB4 cell line to physiological levels of ATRA. • Reformation of PML nuclear bodies is a key to ATRA-induced differentiation of acute promyelocytic leukemia. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
12. Transcriptional regulation of TacL-mediated lipoteichoic acids biosynthesis by ComE during competence impacts pneumococcal transformation.
- Author
-
Yao M, Wang K, Song G, Hu Y, Chen J, Li T, Liang L, Wu J, Xu H, Wang L, Zheng Y, Zhang X, Yin Y, Yao S, and Wu K
- Subjects
- Transcription, Genetic, Promoter Regions, Genetic, DNA Transformation Competence, Mutation, Protein Binding, Ligases genetics, Ligases metabolism, Teichoic Acids biosynthesis, Teichoic Acids metabolism, Bacterial Proteins genetics, Bacterial Proteins metabolism, Lipopolysaccharides biosynthesis, Gene Expression Regulation, Bacterial, Streptococcus pneumoniae genetics, Streptococcus pneumoniae metabolism, Transformation, Bacterial
- Abstract
Competence development is essential for bacterial transformation since it enables bacteria to take up free DNA from the surrounding environment. The regulation of teichoic acid biosynthesis is tightly controlled during pneumococcal competence; however, the mechanism governing this regulation and its impact on transformation remains poorly understood. We demonstrated that a defect in lipoteichoic acid ligase (TacL)-mediated lipoteichoic acids (LTAs) biosynthesis was associated with impaired pneumococcal transformation. Using a fragment of tacL regulatory probe as bait in a DNA pulldown assay, we successfully identified several regulatory proteins, including ComE. Electrophoretic mobility shift assays revealed that phosphomimetic ComE, but not wild-type ComE, exhibited specific binding to the probe. DNase I footprinting assays revealed the specific binding sequences encompassing around 30 base pairs located 31 base pairs upstream from the start codon of tacL . Expression of tacL was found to be upregulated in the Δ comE strain, and the addition of exogenous competence-stimulating peptide repressed the tacL transcription in the wild-type strain but not the Δ comE mutant, indicating that ComE exerted a negative regulatory effect on the transcription of tacL . Mutation in the JH2 region of tacL upstream regulatory sequence led to increased LTAs abundance and displayed higher transformation efficiency. Collectively, our work identified the regulatory mechanisms that control LTAs biosynthesis during competence and thereby unveiled a repression mechanism underlying pneumococcal transformation., Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest., (Copyright © 2024 Yao, Wang, Song, Hu, Chen, Li, Liang, Wu, Xu, Wang, Zheng, Zhang, Yin, Yao and Wu.)
- Published
- 2024
- Full Text
- View/download PDF
13. CD5L attenuates allergic airway inflammation by expanding CD11c high alveolar macrophages and inhibiting NLRP3 inflammasome activation via HDAC2.
- Author
-
Weng D, Gao S, Shen H, Yao S, Huang Q, Zhang Y, Huang W, Wang Y, Zhang X, Yin Y, and Xu W
- Subjects
- Animals, Apoptosis Regulatory Proteins metabolism, Bronchoalveolar Lavage Fluid, CD11c Antigen metabolism, Disease Models, Animal, Histone Deacetylase 2, Inflammasomes metabolism, Inflammation, Lung, Mice, NLR Family, Pyrin Domain-Containing 3 Protein metabolism, Ovalbumin, Receptors, Scavenger metabolism, Asthma, Macrophages, Alveolar
- Abstract
Allergic asthma is an airway inflammatory disease dominated by type 2 immune responses and there is currently no curative therapy for asthma. CD5-like antigen (CD5L) has been known to be involved in a variety of inflammatory diseases. However, the role of CD5L in allergic asthma remains unclear. In the present study, mice were treated with recombinant CD5L (rCD5L) during house dust mite (HDM) and ovalbumin (OVA) challenge to determine the role of CD5L in allergic asthma, and the underlying mechanism was further explored. Compared with PBS group, serum CD5L levels of asthmatic mice were significantly decreased, and the levels of CD5L in lung tissues and bronchoalveolar lavage fluid (BALF) were significantly increased. CD5L reduced airway inflammation and Th2 immune responses in asthmatic mice. CD5L exerted its anti-inflammatory function by increasing CD11c
high alveolar macrophages (CD11chigh AMs), and the anti-inflammatory role of CD11chigh AMs in allergic asthma was confirmed by CD11chigh AMs depletion and transfer assays. In addition, CD5L increased the CD5L+ macrophages and inhibited NLRP3 inflammasome activation by increasing HDAC2 expression in lung tissues of asthmatic mice. Hence, our study implicates that CD5L has potential usefulness for asthma treatment., (© 2022 The Authors. Immunology published by John Wiley & Sons Ltd.)- Published
- 2022
- Full Text
- View/download PDF
14. Molecular Epidemiology and Clinical Features of Enteroviruses-Associated Hand, Foot, and Mouth Disease and Herpangina Outbreak in Zunyi, China, 2019.
- Author
-
Ai Y, Zhang W, Wu J, Zhang J, Shen M, Yao S, Deng C, Li X, Wu D, Tian P, Cheng X, Zha H, and Wu K
- Abstract
Background: Hand, foot and mouth disease (HFMD) and herpangina (HA), two of the most common childhood infectious diseases, are associated with enteroviruses (EVs) infection. The aim of this study was to identify the molecular epidemiology of enterovirus causing HFMD/HA in Zunyi, China, during 2019, and to describe the clinical features of the cases. Methods: We collected the information on demographic and clinical characteristics, laboratory data of laboratory-confirmed EVs associated HFMD/HA cases in Zunyi Medical University Third Affiliated Hospital between March 1 and July 31, 2019. EV types were determined by either one-step real time RT-PCR or partial VP1 gene sequencing and sequence alignment. Phylogenetic analysis of CVA6, CVA2, and CVA5 were established based on the partial VP1 gene sequences by neighbor-joining method. Differences in clinical characteristics and laboratory results of the cases were compared among patients infected with the most prevalent EV types. Results: From 1 March to 31 July 2019, 1,377 EVs associated HFMD/HA inpatients were confirmed. Of them, 4 (0.3%, 4/1,377) were EV-A71-associated cases, 84 (6.1%, 84/1,377) were CVA16-associated cases, and 1,289 (93.6%, 1,289/1,377) were non-EV-A71/CVA16-associated cases. Of the randomly selected 372 non-EV-A71/CVA16 cases, EV types have been successfully determined in 273 cases including 166 HFMD and 107 HA cases. For HFMD cases, the three most common types were CVA6 (80.7%, 134/166), CVA2 (5.4%, 9/166) and CVA5 (3.0%, 5/166); similarly, for HA cases, the three most prevalent serotypes were CVA6 (36.5%, 39/107), CVA2 (21.5%, 23/107) and CVA5 (18.7%, 20/107). Phylogenetic analysis showed that subclade D of CVA5, and subclade E of CVA6 and CVA2 were predominant in Zunyi during the outbreak in 2019. Compared with the cases caused by CVA16, the incidence of high fever and severe infection associated with CVA2, CVA5, and CVA6 was higher. Conclusions: The recent HFMD/HA outbreak in Zunyi is due to a larger incidence of CVA6, CVA2, and CVA5. Novel diagnostic reagents and vaccines against these types would be important to monitor and control EV infections., Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest., (Copyright © 2021 Ai, Zhang, Wu, Zhang, Shen, Yao, Deng, Li, Wu, Tian, Cheng, Zha and Wu.)
- Published
- 2021
- Full Text
- View/download PDF
15. RAS-Responsive Element-Binding Protein 1 Blocks the Granulocytic Differentiation of Myeloid Leukemia Cells.
- Author
-
Yao J, Zhong L, Zhong P, Liu D, Yuan Z, Liu J, Yao S, Zhao Y, Chen M, Li L, Liu L, and Liu B
- Subjects
- Cell Differentiation drug effects, Cell Differentiation physiology, DNA-Binding Proteins biosynthesis, DNA-Binding Proteins deficiency, DNA-Binding Proteins genetics, Gene Knockdown Techniques, Granulocytes drug effects, HL-60 Cells, Humans, Leukemia, Myeloid, Acute genetics, Leukemia, Myeloid, Acute metabolism, MicroRNAs antagonists & inhibitors, MicroRNAs biosynthesis, MicroRNAs genetics, Signal Transduction, Transcription Factors biosynthesis, Transcription Factors deficiency, Transcription Factors genetics, Tretinoin pharmacology, ras Proteins metabolism, DNA-Binding Proteins metabolism, Granulocytes pathology, Leukemia, Myeloid, Acute pathology, Transcription Factors metabolism
- Abstract
RAS-responsive element-binding protein 1 (RREB1) is a transcription factor that is implicated in RAS signaling and multiple tumors. However, the role of RREB1 in acute myeloid leukemia has not been studied. We found that RREB1 is overexpressed in AML patients and myeloid leukemia cell lines (NB4 and HL-60), and RREB1 expression was significantly decreased during granulocytic differentiation of myeloid leukemia cells induced by all- trans retinoic acid (ATRA). Then we performed a RREB1 knockdown assay in NB4 and HL-60 cells; the results showed that knockdown of RREB1 upregulated expression of CD11b, CEBPβ, and microRNA-145 (miR-145), which hinted that knockdown of RREB1 enhanced granulocytic differentiation of myeloid leukemia cells. In addition, inhibitor of miR-145 can offset the enhanced effect on granulocytic differentiation mediated by downregulation of RREB1. These collective findings demonstrated that RREB1 blocks granulocytic differentiation of myeloid leukemia cells by inhibiting the expression of miR-145 and downstream targets of the RAS signal pathway. These may provide a promising therapeutic target for AML patients.
- Published
- 2019
- Full Text
- View/download PDF
16. Epigallocatechin-3-gallate promotes all-trans retinoic acid-induced maturation of acute promyelocytic leukemia cells via PTEN.
- Author
-
Yao S, Zhong L, Chen M, Zhao Y, Li L, Liu L, Xu T, Xiao C, Gan L, Shan Z, and Liu B
- Subjects
- Catechin administration & dosage, Cell Differentiation drug effects, Chromones administration & dosage, Drug Resistance, Neoplasm drug effects, Drug Resistance, Neoplasm genetics, Gene Expression Regulation, Neoplastic drug effects, HL-60 Cells, Humans, Leukemia, Promyelocytic, Acute genetics, Leukemia, Promyelocytic, Acute pathology, Leupeptins administration & dosage, Morpholines administration & dosage, PTEN Phosphohydrolase antagonists & inhibitors, Phenanthrenes administration & dosage, Promyelocytic Leukemia Protein antagonists & inhibitors, Proteolysis drug effects, Retinoic Acid Receptor alpha antagonists & inhibitors, Tretinoin administration & dosage, Catechin analogs & derivatives, Leukemia, Promyelocytic, Acute drug therapy, PTEN Phosphohydrolase genetics, Promyelocytic Leukemia Protein genetics, Retinoic Acid Receptor alpha genetics
- Abstract
Acute promyelocytic leukemia (APL) is a distinctive subtype of acute myeloid leukemia (AML) in which the hybrid protein promyelocytic leukemia protein/retinoic acid receptor α (PML/RARα) acts as a transcriptional repressor impairing the expression of genes that are critical to myeloid cell mutation. We aimed at explaining the molecular mechanism of green tea polyphenol epigallocatechin-3-gallate (EGCG) enhancement of ATRA-induced APL cell line differentiation. Tumor suppressor phosphatase and tensin homolog (PTEN) was found downregulated in NB4 cells and rescued by proteases inhibitor MG132. A significant increase of PTEN levels was found in NB4, HL-60 and THP-1 cells upon ATRA combined with EGCG treatment, paralleled by increased myeloid differentiation marker CD11b. EGCG in synergy with ATRA promote degradation of PML/RARα and restores PML expression, and increase the level of nuclear PTEN. Pretreatment of PTEN inhibitor SF1670 enhances the PI3K signaling pathway and represses NB4 cell differentiation. Moreover, the induction of PTEN attenuated the Akt phosphorylation levels, pretreatment of PI3K inhibitor LY294002 in NB4 cells, significantly augmented the cell differentiation and increased the expression of PTEN. These results therefore indicate that EGCG targets PML/RARα oncoprotein for degradation and potentiates differentiation of promyelocytic leukemia cells in combination with ATRA via PTEN.
- Published
- 2017
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.